Status:
COMPLETED
Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4
Lead Sponsor:
University of Copenhagen
Conditions:
Chronic Kidney Disease, Stage 3 (Moderate)
Eligibility:
All Genders
Phase:
NA
Brief Summary
Hyperphosphatemia is a severe complication to chronic kidney disease (CKD) and is associated with increased risk of vascular calcification, cardiovascular morbidity and mortality. Early dietary interv...
Detailed Description
Development of the New Nordic Renal Diet The NND was not suitable for CKD patients in its present form because of too high phosphorus content. By going through the diet composition in details and redu...
Eligibility Criteria
Inclusion
- Estimated glomerular filtration rate (eGFR) 16 to 45 ml/min/1.73 m2, as judged by CKD-EPI equation
- Medically stable for 2 months before and during the study
- No food allergies
- Ability to understand the Danish language orally and in writing
Exclusion
- \- Intake of phosphate binders
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2017
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03472105
Start Date
February 1 2017
End Date
November 6 2017
Last Update
November 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arne V. Astrup
Copenhagen, Denmark